Loose Cannon: Pharmas Ask, Tube Be, or Not Tube Be?
Disturbing news from the media-buying front this week, folks: It seems that pharmaceutical players are cutting their television advertising, according to the Wall Street Journal.
Why did the pill companies pull back on their spots? Perhaps they reviewed the number of calls to fulfillment centers, or Web hits, when their commercials ran. They might have even been looking at that delightfully anachronistic metric, change in sales.
At the risk of turning their attentions from other direct response mediums, I
